Monthly Archives: April 2016

The task now is identifying people who don’t know they’re infected and connecting them to care


The experts from the European Liver Patients Association (ELPA) Hep-CORE advisory group provide a great window on the diversity of hepatitis activity and perspectives in the region. In this series of short interviews, Hep-CORE PI Jeffrey Lazarus asked them how they came to work with viral hepatitis, how the field has been changing, and where new research is called for.


UNGASS 2016 commentary series: blue lights and drug injection


The United Nations General Assembly Special Session (UNGASS) on drugs will convene in April 2016 to debate what to do about the international agreement on drug policy. As part of our commentary on the meeting, we look back on the public health concerns and the drug policies meant to combat them. Here, authors in Harm Reduction Journal discuss their research into the installation of blue lights in public washrooms to deter drug use.


The science behind running: technique and injury


BioMed Central’s Community Manager, Sophie Marchant, as well as thousands of others across the world, will soon be taking part in her first marathon. In the weeks leading up to the event, she looks at some of the research that’s been carried out on running, starting with every runner’s worst nightmare: injury.